WARF startup focuses on development of portable device to identify onset of serious infections
MADISON, Wis. – Neil Holland has been named chief executive officer of Isomark, a startup company based on technology developed at the University of Wisconsin–Madison to identify the early onset of bacterial infections, including serious hospital-related infections such as sepsis.

Holland has more than 25 years of medical device industry management experience and previously served as vice president of global device research and development with Hospira, a $4 billion global leader in injectable pharmaceuticals and medication delivery systems. At Hospira, he was responsible for the development and market launch of infusion pumps, cardiac monitors, medication management software, wireless connectivity systems and clinical decision support software.

Holland’s most recent work as president of Medical Product Consulting, developing business strategy in imaging and diagnostic...